Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10874526 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Available Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
Conditions: Infection, Soft Tissue;   Infection, Wound;   Cellulitis;   Foot Ulcer, Diabetes
Interventions: Drug: Cefazolin;   Device: Silberg Tissue Preparation System

Indicates status has not been verified in more than two years